|
|
| Maladies Respiratoires > Etude de marché sectorielle |
| Pulmonary Drug Delivery Technologies |
|
|
|
|
€ 3 012,00 |
Editeur
: |
Global Industry Analyst |
Langue
: |
Anglais |
Date de publication : |
Octobre 2005 |
Taille du document : |
362 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (5) |
|
|
|
| 86 pages | Août 2005 | Anglais
|
|
|
| Main
focus: |
pharmaceuticals,pharmaceutical,pharmacovigilance
|
| Research
focus: |
industry structure,market size and estimates, |
| Geographic
focus: |
usa,united kingdom,india,germany,thailand,nigeria,... |
| |
|
|
|
|
| 96 pages | Juillet 2006 | Anglais
|
|
|
| Main
focus: |
pharmaceuticals,pharmaceutical,...,banks
|
| Research
focus: |
market size and estimates,market definition, |
| Geographic
focus: |
usa,china,france,canada,bermuda,israel,japan,india,... |
| |
|
|
|
|
| 64 pages | Mars 2005 | Anglais
|
|
|
| Main
focus: |
pharmaceuticals,atherosclerosis,hypertension
|
| Research
focus: |
market size and estimates,market outlook, |
| Geographic
focus: |
usa,france,canada |
| |
|
|
|
|
| 64 pages | Novembre 2005 | Anglais
|
|
|
| Main
focus: |
pharmaceuticals,dyslipidemia,pharmaceutical,...,...
|
| Research
focus: |
market size and estimates,market outlook, |
| Geographic
focus: |
usa,france,canada,poland |
| |
|
|
|
|
| 70 pages | Septembre 2006 | Anglais
|
|
|
| Main
focus: |
pharmaceuticals,pharmaceutical,...
|
| Research
focus: |
market size and estimates,industry structure, |
| Geographic
focus: |
india,usa,china,france,united kingdom,malaysia,... |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Travel and Tourism Canada
36 pages | Février 2005 |
About this report2003 was a grim year for the tourism industry worldwide but Canada was particularly afflicted by the downturn in travel.
As well as external factors such as the Iraq war, which cur |
445,00 €
|
| |
| |
UK Hayfever Remedies 2004
13 pages | Juillet 2004 |
Snapdata's UK Hayfever Remedies 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the UK hayfever remedy market, a |
240,00 €
|
| |
| |
The Global Diabetes Market: Therapeutics, Diagnostics and Complications
218 pages | Août 2006 |
Diabetes is one of the largest therapeutic segments of global pharmaceutical sales and during the last 10 years it has grown by a compound average growth rate of nearly 20% from around US$4 billion in |
1 999,20 €
|
| |
| |
Inhalable Drug Delivery: Industry Holds its Breath in Anticipation of Systemic Success
124 pages | Décembre 2005 |
IntroductionCurrently driven by the needs of the expanding respiratory market, the inhalable drug delivery sector has also been invigorated by the promise of growth through the systemic delivery of dr |
6 460,00 €
|
| |
| |
Stakeholder Insight: Asthma - Combination Therapy Appropriate for Everyone?
184 pages | Janvier 2005 |
Web DescriptionIntroductionAccording to the US National Heart, Lung, and Blood Institute and the European Respiratory Society, the annual cost of asthma is estimated to be $16.1 billion in the US and |
12 160,00 €
|
| |
| |
US Nasal Products 2005
13 pages | Juin 2005 |
Snapdata's US Nasal Products 2005 report provides 2004 year-end market data, with 2005 estimates and five-year forecasts.
The report gives an instant overview of the US nasal product market, and co |
240,00 €
|
| |
| |
Travel and Tourism - Poland
34 pages | Août 2006 |
About this reportSince its break with communism in 1989 and its first democratic election Poland has become an increasingly popular destination choice for foreign tourists.
This diverse country boa |
445,00 €
|
| |
| |
UK Market For Personal Protective Equipment
80 pages | Mai 2002 |
This report will enable you to:Analyse the size of the UK market for personal protective equipment, in volume terms, 1997-2006Quantify the size of the UK market for personal protective equipment bet |
700,00 €
|
| |
| |
US Cough, Cold & Throat Remedies 2005
15 pages | Juin 2005 |
Snapdata's US Cough, Cold & Throat Remedies 2005 report provides 2004 year-end market data, with 2005 estimates and five-year forecasts.
The report gives an instant overview of the US cough cold an |
240,00 €
|
| |
| |
Stakeholder Perspectives: Pulmonary Arterial Hypertension - A small market gets big attention
59 pages | Février 2006 |
IntroductionDatamonitor expects the global pulmonary arterial hypertension (PAH) market to grow from $636m in 2004 to just over $2 billion by 2014, as new product and formulation launches in the US an |
6 460,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Pulmonary Drug Delivery Technologies |
|
|
This report analyzes the worldwide markets for Pulmonary Drug Delivery Technologies in Millions of US$. The specific product segments analyzed are Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), and Nebulizers. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World. Annual forecasts are provided for each region and product segment for the period of 2000 through 2010. The report profiles 52 companies including many key and niche players worldwide such as and Aerogen Inc, Alkermes Inc, Alliance Pharmaceutical Corp, Aradigm, AstraZeneca Plc, Bespak Europe Ltd, Chiesi Farmaceutici SpA, Dey L.P., Epic Therapeutics Inc., Generex Biotechnology Corp, GlaxoSmithkline, Inyx Inc, LAB International Inc, Focus Inhalation OY, 3M Pharmaceuticals, 3M Drug Delivery Systems Division (DDS), Nektar Therapeutics, Omron Healthcare Co Ltd., Oriel Therapeutics Inc., Sepractor Inc, SkyePharma Plc, Vectura, and Ventaira Pharmaceuticals Inc.
|
|
Pulmonary Drug Delivery Technologies
|
|
|
PPLSEN
|
|
|
|
|
